Gold prices edge up but set for weekly drop as US inflation data weighs

Spot gold was trading at $3,339 per ounce, up 0.1% as of 0244 GMT, while US gold futures for December delivery held steady at $3,384 an ounce.

Spot gold was trading at $3,339 per ounce, up 0.1% as of 0244 GMT, while US gold futures for December delivery held steady at $3,384 an ounce.

The NSE and BSE will be shut for all trading activities, including equities, equity derivatives, and the securities lending and borrowing (SLB) segment. The markets will resume trading on Monday, August 18.

Vedanta stated that the warning letter is cautionary in nature and does not impose any financial or operational restrictions on the company. The development has no material impact on the company’s financials, operations, or the modified Scheme. Shares of Vedanta…

Bulk deal data from the NSE showed Sun Life Excel India Fund buying nearly six lakh shares for close to ₹18 crore at an average price of ₹302.90 apiece.

The company stated that it will continue to explore both organic and inorganic growth opportunities. It added that the withdrawal will have no material or financial impact, as the transaction was still at a preliminary stage. Shares of Allied Blenders…

According to the company’s disclosure, Ratra tendered his resignation through a letter dated August 14, 2025. His resignation will be effective from October 6, 2025. Shares of IIFL Finance Ltd ended at ₹441.10, down by ₹4.75, or 1.07%, on the…

The scope of work includes surveying, soil investigation, engineering, design, and supply of all required materials, labour, and tools for the construction, completion, testing, and commissioning of several components. Shares of EMS Ltd ended at ₹550.15, down by ₹2.20, or…

Average pay for Nifty50 chiefs fell 10.3% to ₹25.1 crore in FY25, weighed down by sharp IT pay cuts and index changes, even as corporate profits and revenues rose.

Borosil’s Q1FY26 net profit rose 87% year-on-year to ₹17.4 crore, compared to ₹9.3 crore in the same period last year. Shares of the company ended lower on Thursday (August 14) by 0.79% at ₹332.05 on the NSE.

EBITDA dipped 1.4% to ₹580 crore in the first quarter compared to ₹588.2 crore a year ago. The EBITDA margin was lower at 17.7% versus 18.1% in Q1FY25. Shares of Glenmark Pharmaceuticals Ltd ended at ₹2,038.95, up by ₹7.15 or…